A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Thyroglobulin, Tumor Marker - Serum (To Mayo Direct)
Test CodeLAB6129
Alias/See Also
THYRM, HTG2, 83069, LOINC: 3013-0
CPT Codes
84432
Includes
Thyroglobulin Antibody,
Thyroglobulin, Tumor Marker,
Thyroglobulin Interpretation
Thyroglobulin, Tumor Marker,
Thyroglobulin Interpretation
Preferred Specimen
2 mL Serum
Collection Container/Tube: Red top No SST
Collection Container/Tube: Red top No SST
Patient Preparation
Patient Preparation: For 12 hours before specimen collection do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.
Minimum Volume
1 mL
Instructions
Collection Instructions: Red-top tubes should be centrifuged and aliquot serum into plastic tube.
Transport Container
Plastic screw-top aliquot tube
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated (preferred) 7 days
Frozen 30 days
Frozen 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis or Icterus: Mild OK; Gross reject
Lipemia OK
Lipemia OK
Methodology
Immunoenzymatic Assay
Setup Schedule
Mayo-Rochester: Monday through Friday 6 a.m. - 12 a.m., Saturday 6 a.m. - 6 p.m., Maximum time in Lab: 3 Days
Report Available
7 Days
Limitations
It has been determined that the presence of anti-thyroglobulin autoantibodies (TgAb), in serum can lead to underestimation of Tg concentration by immunometric methods. When TgAb are present in samples with detectable Tg, the Tg values may be underestimated by up to 60% in immunoassays. In addition, approximately 20% of specimens containing TgAb which are negative for Tg by immunoassay tested positive by LC-MS/MS. Therefore, measuring of Tg by mass spectrometry is the preferred method in TgAb positive patients.
Reference Range
THYROGLOBULIN, TUMOR MARKER: Athyrotic: <0.1 ng/mL, Intact thyroid < or =33 ng/mL
THYROGLOBULIN ANTIBODY: < 1.8 IU/mL (Note: values less then 1.8 will be reported as <1.8 IU/mL)
Refer to Mayo HTG2 link below for additional information.
Clinical Significance
Follow-up of patients with differentiated thyroid cancers after thyroidectomy and radioactive iodine ablation
Performing Laboratory
Mayo Clinic Laboratories
Additional Information
MayoMedicalLaboratories_HTG2_Link